⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTC News
Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc. Announces Proposed Public Offering
globenewswire.com
BNTC
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
globenewswire.com
BNTC
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
globenewswire.com
BNTC
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
globenewswire.com
BNTC